Lunesta, Crestor, Sanctura Among New Products In UnitedHealth Registry

 
• By The Pink Sheet

Sepracor's insomnia agent Lunesta, AstraZeneca's statin Crestor and Indevus' overactive bladder therapy Sanctura are among the new products to be included in UnitedHealth's postmarketing surveillance drug registry

More from Archive

More from Pink Sheet